Grid Therapeutics signs license agreement with Duke University for CFH antibodies for cancer Aug. 24, 2017
CRISPR Therapeutics and Massachusetts General Hospital collaborate to develop T-cell therapies Aug. 23, 2017
VAX-DC/MM immunotherapy shows disease stabilizing activity in heavily pretreated multiple myeloma Aug. 21, 2017
ViraCyte receives CPRIT grant from the Cancer Prevention and Research Institute of Texas Aug. 18, 2017
RSS